- Home
- KRMD vs JHS Comparison
KRMD vs JHS Comparison
Compare KRMD & JHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- JHS
- Stock Information
- Founded
- KRMD 1980
- JHS 1973
- Country
- KRMD United States
- JHS United States
- Employees
- KRMD N/A
- JHS N/A
- Industry
- KRMD Medical/Dental Instruments
- JHS Finance Companies
- Sector
- KRMD Health Care
- JHS Finance
- Exchange
- KRMD Nasdaq
- JHS Nasdaq
- Market Cap
- KRMD 134.3M
- JHS 131.4M
- IPO Year
- KRMD N/A
- JHS N/A
- Fundamental
- Price
- KRMD $3.38
- JHS $11.06
- Analyst Decision
- KRMD Strong Buy
- JHS
- Analyst Count
- KRMD 4
- JHS 0
- Target Price
- KRMD $4.63
- JHS N/A
- AVG Volume (30 Days)
- KRMD 158.9K
- JHS 32.8K
- Earning Date
- KRMD 08-06-2025
- JHS 01-01-0001
- Dividend Yield
- KRMD N/A
- JHS 3.96%
- EPS Growth
- KRMD N/A
- JHS N/A
- EPS
- KRMD N/A
- JHS 0.02
- Revenue
- KRMD $35,083,740.00
- JHS N/A
- Revenue This Year
- KRMD $18.16
- JHS N/A
- Revenue Next Year
- KRMD $14.60
- JHS N/A
- P/E Ratio
- KRMD N/A
- JHS $553.50
- Revenue Growth
- KRMD 19.65
- JHS N/A
- 52 Week Low
- KRMD $1.86
- JHS $9.76
- 52 Week High
- KRMD $5.05
- JHS $11.25
- Technical
- Relative Strength Index (RSI)
- KRMD 68.27
- JHS 40.79
- Support Level
- KRMD $3.15
- JHS $11.03
- Resistance Level
- KRMD $3.38
- JHS $11.14
- Average True Range (ATR)
- KRMD 0.19
- JHS 0.09
- MACD
- KRMD 0.03
- JHS -0.01
- Stochastic Oscillator
- KRMD 90.91
- JHS 9.38
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About JHS John Hancock Income Securities Trust
John Hancock Income Securities Trust is a United States-based closed-ended diversified management investment company. Its primary objective is to generate a high level of current income consistent with prudent investment risk. The fund invests its net assets (plus borrowings for investment purposes) in income securities, consisting of marketable corporate debt securities, governmental obligations, and cash and commercial paper. A majority of its net assets are invested in debt securities that are rated, at the time of acquisition, investment-grade or in unrated securities determined by the Fund's investment advisor or subadvisor to be of comparable credit quality.